SMTL ID : 7uzn.1

CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH BMT-206059 AKA 2-{(3M)-3-(1,4-DIMETHYL-1H-1,2,3-TRIAZOL-5-YL)-8-FLUORO-5-[(S)-(OXAN-4-YL)(PHENYL)METHYL]-5H-PYRIDO[3,2-b]INDOL-7-YL}PROPAN-2-OL, TRIPLY DEUTERATED ON THE 4-METHYL GROUP

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x PQF: 2-{(3M)-3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-8-fluoro-5-[(S)-(oxan-4-yl)(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl}propan-2-ol(Non-covalent)

PQF.1: 14 residues within 4Å: Chain A: W.41, P.42, F.43, Q.45, V.47, L.52, L.54, Y.57, C.96, Y.99, N.100, D.105, I.106, M.109 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.41, A:L.52, A:L.52, A:L.54, A:L.54, A:I.106 Hydrogen bonds: A:N.100 Water bridges: A:Y.57 pi-Stacking: A:W.41

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 4 residues within 4Å: Chain A: Y.97, N.100, K.101, P.102 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.98

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 2 residues within 4Å: Chain A: P.16, K.17 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.17 EDO.4: 6 residues within 4Å: Chain A: I.60, I.61, K.62, T.63, N.95, I.98 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:I.60, A:K.62, A:T.63, A:N.95, A:N.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hill, M.D. et al., Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties. Acs Med.Chem.Lett. (2022)

Release Date

2022-08-17

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence